Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
about
Neuroleptic malignant syndrome.Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented PerspectiveCombined neuroleptic malignant syndrome and the central anticholinergic syndromeFits and startsLevodopa withdrawal syndrome identical to neuroleptic malignant syndromeCerebellar syndrome following neuroleptic induced heat strokeA case of neuroleptic malignant syndrome in a patient with hemodialysisThe syndrome of Karl Ludwig Kahlbaum.Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathologyHeat stress and neuroleptic drugs.Neuroleptic malignant syndrome due to sulpiride.Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen.Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis.Neuroleptic malignant syndrome: a review for neurohospitalistsRhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate.Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.RETRACTED: Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.Missed neuroleptic malignant syndrome.The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.Neuroleptic toxicity syndromes: a clinical spectrum.Intraoperative hyperthermia: Can surgery itself be a cause?Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.Neuroleptic malignant syndrome: a neuroimmunologic hypothesis.Neuroleptic malignant syndrome in the intensive therapy unit.Pineal melatonin functions: possible relevance to Parkinson's disease.Pharmacologic effects on thermoregulation: mechanisms of drug-related heatstroke.The neuroleptic malignant syndrome: agent and host interaction.The hypothalamus in Parkinson disease.Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome?Hemorheological aspects of the pathophysiology of cerebral ischemia.The neuroleptic malignant syndrome. Case report with a review of the literature.A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome.Emergency anaesthetic management of a severely anaemic, chronic schizophrenic patient with history of neuroleptic malignant syndrome.The enzymology of skeletal muscle disorders.Neurotoxic syndrome associated with risperidone and fluvoxamine.Neuroleptic malignant syndrome: two cases without muscle rigidity.Post-traumatic hyperthermia in acute brain injury rehabilitation.A 73-year-old woman with confusion, rigidity, and fever.Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.Diencephalic seizures: responsiveness to bromocriptine and morphine.
P2860
Q24521308-3A6DA332-54B9-4812-804C-482F10CB9F24Q26786284-85702FC9-E391-4032-908E-D9B77FAE5771Q28331415-A503271D-3EAF-4323-B59B-035198B717E9Q28343263-0A52545A-E9CA-49F3-B66A-33A5984C432EQ28362151-1B033EF1-9F89-4FA9-8A27-EC9A0FB60512Q28367465-679393F1-BEC0-42BF-9CD1-152E8B24207AQ28372871-BC58C7E2-A4A3-4621-9A1D-44CDC16B992EQ33622571-F8978B0C-A8C1-4562-BB7B-8E2EFFE9A42BQ33628067-70DD12F6-4469-4642-B76E-C112139E0123Q33628826-B4020D62-748F-4D35-A9AC-036511C8FBA9Q33631282-2E61D662-CCF3-48C2-BFDF-924D46B8EADFQ34201393-DEF61F5B-E2B7-408E-853A-40C484D7F31AQ34335511-1C04FCCC-C8EA-48AA-B008-2694AB6F0F92Q34367132-83ABB410-81BF-42CD-9370-9C95BE866D42Q34522672-A5467485-EADD-41EB-BB9E-296E98FEB09FQ34619015-2ABF232F-303E-4D13-9742-6CA358E59C87Q35473448-D64B2DC6-803A-45FA-A228-8C9B142F1BC4Q35820847-CAD61264-1FC4-4D73-BF36-AEFA861B7C27Q35986088-3625B979-C165-407F-8966-C64BC484DB69Q36545855-DCD9C30C-4385-4EFD-9E5A-820ED7200B99Q37137997-E3602210-FCEE-4A17-BF09-35B280B20829Q37596135-40055EBE-F4F6-4E15-9E36-40B4CE970609Q37778936-3544448B-8513-48C2-BEFB-1C9552126E4DQ37922127-0E685B5B-DCCD-4B57-A90C-15F9D6B87C9AQ38018546-6E5720DB-DEF1-498C-98A9-3915A5831540Q38741814-8A58960B-1B8F-405E-BF8B-A3AFBE0C65D5Q39453882-687EBEC3-96DA-4D41-B779-7A95175F15F1Q39463738-E58A5CEB-BD32-4748-94B9-084A424F5992Q39539430-EB4907F3-0821-40F9-934D-00DC2E96DE05Q39655738-94F7459F-1D1D-4D2B-9D68-5FA98D9B9A93Q39804792-60F00B57-6E45-4ABA-80FC-E3457D96AA93Q39852834-08B46C1C-832D-4F3E-92DB-B3209E137D3BQ40110359-48CFDF0A-F019-4295-A27C-517A10362040Q40177484-FE066D12-EE4A-4BFA-A8AD-D94D096B55A8Q40586733-310960F5-DCAB-4250-AAF2-74D1C8AEB717Q40667422-ACD0B0C8-E27C-47F9-BB23-C490A8A73A68Q40701147-04BF0E3C-1F80-42B2-9F14-ABE878AE0D53Q40747579-02F1010C-20BE-40C6-9AC1-1D4ADDAFB260Q40835087-30B7D306-1992-4CB5-B560-BEFA3035FB63Q41372089-1112E248-CFAA-47FD-B495-7FB5A03FD5BB
P2860
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
description
1981 nî lūn-bûn
@nan
1981 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@ast
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@en
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@nl
type
label
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@ast
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@en
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@nl
prefLabel
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@ast
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@en
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@nl
P356
P1433
P1476
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
@en
P2093
Henderson VW
P304
P356
10.1212/WNL.31.2.132
P407
P577
1981-02-01T00:00:00Z